TerminatedNCT04278755
Binge Eating & Birth Control
Medication studyAges 18–34United StatesEating disorders
Understand this study
Who could participate?
Listed age limits: 18 years to 34 years.
- Listed locations
- Chapel HillSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 24, 2020
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 8
- Sponsor
- University of North Carolina, Chapel Hill
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 34 Years
- Official registry ID
- NCT04278755
- Official title
Show the full official title
A Mechanistic Examination of Continuous Cycle Oral Contractive Administration in Binge Eating
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Chapel Hill
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of North Carolina, Chapel Hill, a university.
Does this study involve medication?
Yes. The study involves medication, including Drospirenone-Ethinyl Estradiol Oral Tablet.
Who can participate?
Listed age limits: 18 years to 34 years.
Is this study still recruiting?
The registry lists this study as terminated.
